124 related articles for article (PubMed ID: 9493701)
1. Barnidipine, a novel calcium antagonist for once-daily treatment of hypertension: a multicenter, double-blind, placebo-controlled, dose-ranging study. Dutch Barnidipine Multicenter Study Group.
Hart W; Holwerda NJ
Cardiovasc Drugs Ther; 1997 Nov; 11(5):637-43. PubMed ID: 9493701
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of once-daily barnidipine in the clinical management of patients with mild to moderate essential hypertension.
Spieker C
Blood Press Suppl; 1998; 1():15-21. PubMed ID: 9660522
[TBL] [Abstract][Full Text] [Related]
3. The long-term efficacy and safety profile of barnidipine.
Smilde JG
Int J Clin Pract Suppl; 2000 Nov; (114):20-6. PubMed ID: 11221291
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hypertension in the very old.
Otterstad JE; Ruilope LM
Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289
[TBL] [Abstract][Full Text] [Related]
5. Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study.
Lins R; Haerden Y; de Vries C
High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):29-36. PubMed ID: 28058623
[TBL] [Abstract][Full Text] [Related]
6. Distinct vasodilation, without reflex neurohormonal activation, induced by barnidipine in hypertensive patients.
Argenziano L; Izzo R; Iovino G; De Luca N; Parrella L; Morisco C; Trimarco B
Blood Press Suppl; 1998; 1():9-14. PubMed ID: 9660521
[TBL] [Abstract][Full Text] [Related]
7. An open-label, randomized, controlled, 4-week comparative clinical trial of barnidipine hydrochloride, a calcium-channel blocker, and benazepril, an angiotensin-converting enzyme inhibitor, in Chinese patients with renal parenchymal hypertension.
Chen X; Zheng F; Chen P; Tang L; Wei R; Yu Y; Su Y; Kikkawa T; Yamamoto M
J Int Med Res; 2006; 34(2):121-8. PubMed ID: 16749407
[TBL] [Abstract][Full Text] [Related]
8. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the antihypertensive effect of barnidipine, a dihydropyridine calcium entry blocker, as determined by the ambulatory blood pressure level averaged for 24 h, daytime, and nighttime. Barnidipine Study Group.
Imai Y; Abe K; Nishiyama A; Sekino M; Yoshinaga K
Am J Hypertens; 1997 Dec; 10(12 Pt 1):1415-9. PubMed ID: 9443779
[TBL] [Abstract][Full Text] [Related]
10. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of barnidipine and felodipine in Chinese patients with essential hypertension.
Zhu W; Li T; Ni C; Liu H; Fang L; Shang M; Kikkawa T; Katoh H; Yamamoto M
J Int Med Res; 2006; 34(4):406-12. PubMed ID: 16989497
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of barnidipine compared with felodipine in the treatment of hypertension in Chinese patients.
Liau CS; Chien KL; Chao CL; Lee TM
J Int Med Res; 2002; 30(3):330-6. PubMed ID: 12166353
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
[TBL] [Abstract][Full Text] [Related]
14. Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus.
Derosa G; Mugellini A; Pesce RM; D'Angelo A; Maffioli P
BMC Cardiovasc Disord; 2016 Apr; 16():66. PubMed ID: 27068332
[TBL] [Abstract][Full Text] [Related]
15. Diversity and intensity of adverse events in the treatment of hypertension with barnidipine.
van der Velden JW; Beudeker HJ; Nishi M
Blood Press Suppl; 1998; 1():27-9. PubMed ID: 9660524
[TBL] [Abstract][Full Text] [Related]
16. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
Leonetti G;
Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study.
Parati G; Giglio A; Lonati L; Destro M; Ricci AR; Cagnoni F; Pini C; Venco A; Maresca AM; Monza M; Grandi AM; Omboni S
Clin Ther; 2010 Jul; 32(7):1270-84. PubMed ID: 20678675
[TBL] [Abstract][Full Text] [Related]
18. Nilvadipine in hypertension--experience in ambulatory treatment.
Hoffmann A; Kraul H; Burkardt I
Int J Clin Pharmacol Ther; 1997 May; 35(5):195-203. PubMed ID: 9174874
[TBL] [Abstract][Full Text] [Related]
19. Barnidipine monotherapy and combination therapy in older patients with essential hypertension: a long-term study.
Naber FB; Häge R; Mortelmans J
Int J Clin Pract Suppl; 2000 Nov; (114):27-35. PubMed ID: 11221292
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of lacidipine and nifedipine SR in the treatment of hypertension: an Italian multicenter study. The Northern Italian Study Group of Lacidipine in Hypertension.
Leonetti G
J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S31-4. PubMed ID: 1726003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
